Eli Lilly and Company News - June 4, 2026
🟢 Eli Lilly and Company is trading 5.2% up today on obesity drug enthusiasm and strong institutional demand
Eli Lilly and Company is trading 5.2% up at $1135.25 following fresh enthusiasm around its obesity and diabetes franchise and evidence of strong institutional...
Eli Lilly Surges 4.6% on Weight-Loss Drug Euphoria and Big-Money Buying — But Can the Stock Keep Outrunning Its Own Hype?
Shares of Eli Lilly jumped 4.6% to $1,127.99 on June 4, snapping a week-long slide that saw the stock drop from $1,126.80 to $1,064.15 in just five sessions....
🟢 Eli Lilly is trading 4.6% up today on a new $1.9B genetic medicine deal and a Weight Watchers partnership
Eli Lilly and Company is trading 4.6% up at $1127.99 following the announcement of a major research partnership and expanded access for its weight-loss drug...
🟢 Eli Lilly and Company is trading 4.5% up today on GLP-1 optimism and institutional dip-buying
Eli Lilly and Company is trading 4.5% up at $1126.80 following strong premarket interest and persistent optimism surrounding its GLP-1 obesity and diabetes...